About Trio Pharmaceutials, Inc.
We are a cancer therapeutics company with a mission to improve efficacy, reduce toxicity and increase treatment affordability of cancer drugs. We are an experienced team in cancer drug discovery and development. Team members have invented and developed drugs that are approved for cancer treatment. Our approach to eradicating cancer is distinct from the current standard of care. Current approaches involve single agent single action drugs that either inhibit cancer cell growth or inhibit immunosuppression, and hence, they are ineffective. These drugs are combined in a bid to improve efficacy. But combination leads to toxicity, poor efficacy, and high cost. We are developing single agent dual action treatments inhibiting both cancer growth and immunosuppression. We are not targeting the immune checkpoint axis. Our approach will be effective for cancer patients that failed immune checkpoint treatments due to resistance or low expression of PD1, PDL1, CTLA4 etc..
|
|
|
1-10 employees
View all Trio Pharmaceutials, Inc. employees
|
|
Biotechnology
|
|
+1-619-7863495
|
|
11956 Bernardo Plaza Dr, San Diego, California 92128, US
|
|
2018
|
Trio Pharmaceutials, Inc. Alternatives
Frequently Asked Questions about Trio Pharmaceutials, Inc.
Reiner Laus is the CEO of TRIO Pharmaceuticals, Inc.. To contact Reiner Laus email at [email protected], [email protected] or [email protected].
The decision makers in Trio Pharmaceutials, Inc. are Shiva Bhowmik, William Brady, etc. Click to Find Trio Pharmaceutials, Inc. decision makers emails.
Trio Pharmaceutials, Inc. Staff Directory
Search Trio Pharmaceutials, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
